{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T20:54:27Z","timestamp":1790801667275,"version":"4.1.0"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2015,10,6]],"date-time":"2015-10-06T00:00:00Z","timestamp":1444089600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Clin Microbiol Infect Dis"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1007\/s10096-015-2488-5","type":"journal-article","created":{"date-parts":[[2015,10,6]],"date-time":"2015-10-06T07:29:05Z","timestamp":1444116545000},"page":"2349-2357","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Low efficacy of tobramycin in experimental Staphylococcus aureus endocarditis"],"prefix":"10.1007","volume":"34","author":[{"given":"C. J.","family":"Lerche","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L. J.","family":"Christophersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Tr\u00f8strup","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Thomsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P. \u00d8.","family":"Jensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H. P.","family":"Hougen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Bundgaard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"H\u00f8iby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Moser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,10,6]]},"reference":[{"key":"2488_CR1","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1086\/431979","volume":"41","author":"JM Miro","year":"2005","unstructured":"Miro JM, Anguera I, Cabell CH, Chen AY, Stafford JA, Corey GR et al (2005) Staphylococcus aureus native valve infective endocarditis: report of 566 episodes from the International Collaboration on Endocarditis Merged Database. Clin Infect Dis 41:507\u2013514. doi: 10.1086\/431979","journal-title":"Clin Infect Dis"},{"key":"2488_CR2","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1128\/IAI.01030-12","volume":"81","author":"TR Veloso","year":"2013","unstructured":"Veloso TR, Chaouch A, Roger T, Giddey M, Vouillamoz J, Majcherczyk P et al (2013) Use of a human-like low-grade bacteremia model of experimental endocarditis to study the role of Staphylococcus aureus adhesins and platelet aggregation in early endocarditis. Infect Immun 81:697\u2013703. doi: 10.1128\/IAI.01030-12","journal-title":"Infect Immun"},{"key":"2488_CR3","doi-asserted-by":"crossref","first-page":"3120","DOI":"10.1128\/IAI.69.5.3120-3127.2001","volume":"69","author":"IR Siboo","year":"2001","unstructured":"Siboo IR, Cheung AL, Bayer AS, Sullam PM (2001) Clumping factor A mediates binding of Staphylococcus aureus to human platelets. Infect Immun 69:3120\u20133127. doi: 10.1128\/IAI.69.5.3120-3127.2001","journal-title":"Infect Immun"},{"key":"2488_CR4","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1160\/TH06-11-0640","volume":"97","author":"R Heying","year":"2007","unstructured":"Heying R, van de Gevel J, Que Y-A, Moreillon P, Beekhuizen H (2007) Fibronectin-binding proteins and clumping factor A in Staphylococcus aureus experimental endocarditis: FnBPA is sufficient to activate human endothelial cells. Thromb Haemost 97:617\u2013626","journal-title":"Thromb Haemost"},{"key":"2488_CR5","first-page":"705","volume":"9","author":"I Rawczy\u0144ska-Englert","year":"2000","unstructured":"Rawczy\u0144ska-Englert I, Hryniewiecki T, Dzier\u017canowska D (2000) Evaluation of serum cytokine concentrations in patients with infective endocarditis. J Heart Valve Dis 9:705\u2013709","journal-title":"J Heart Valve Dis"},{"key":"2488_CR6","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1007\/s10156-012-0497-1","volume":"19","author":"T Tsaganos","year":"2013","unstructured":"Tsaganos T, Pelekanou A, Skiadas I, Giamarellos-Bourboulis EJ (2013) Differences in cytokine stimulation between methicillin-susceptible and methicillin-resistant Staphylococcus aureus in an experimental endocarditis model. J Infect Chemother 19:272\u2013278. doi: 10.1007\/s10156-012-0497-1","journal-title":"J Infect Chemother"},{"key":"2488_CR7","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1128\/AAC.38.5.1017","volume":"38","author":"J Mohler","year":"1994","unstructured":"Mohler J, Fantin B, Mainardi JL, Carbon C (1994) Influence of antimicrobial therapy on kinetics of tumor necrosis factor levels in experimental endocarditis caused by Klebsiella pneumoniae. Antimicrob Agents Chemother 38:1017\u20131022. doi: 10.1128\/AAC.38.5.1017","journal-title":"Antimicrob Agents Chemother"},{"key":"2488_CR8","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1111\/apm.12145","volume":"122","author":"JG Christiansen","year":"2014","unstructured":"Christiansen JG, Jensen HE, Jensen LK, Koch J, Aalbaek B, Nielsen OL et al (2014) Systemic inflammatory response and local cytokine expression in porcine models of endocarditis. APMIS 122:292\u2013300. doi: 10.1111\/apm.12145","journal-title":"APMIS"},{"key":"2488_CR9","doi-asserted-by":"crossref","first-page":"2202","DOI":"10.1128\/IAI.02965-14","volume":"83","author":"C-Y Yeh","year":"2015","unstructured":"Yeh C-Y, Shun C-T, Kuo Y-M, Jung C-J, Hsieh S-C, Chiu Y-L et al (2015) Activated human valvular interstitial cells sustain interleukin-17 production to recruit neutrophils in infective endocarditis. Infect Immun 83:2202\u20132212. doi: 10.1128\/IAI.02965-14","journal-title":"Infect Immun"},{"key":"2488_CR10","doi-asserted-by":"crossref","first-page":"2369","DOI":"10.1093\/eurheartj\/ehp285","volume":"30","author":"G Habib","year":"2009","unstructured":"Habib G, Hoen B, Tornos P, Thuny F, Prendergast B, Vilacosta I et al (2009) Guidelines on the prevention, diagnosis, and treatment of infective endocarditis (new version 2009): the task force on the prevention, diagnosis, and treatment of infective endocarditis of the European Society of Cardiology (ESC). Endorsed by the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) and the International Society of Chemotherapy (ISC) for Infection and Cancer. Eur Heart J 30:2369\u20132413. doi: 10.1093\/eurheartj\/ehp285","journal-title":"Eur Heart J"},{"key":"2488_CR11","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1093\/jac\/dkr450","volume":"67","author":"FK Gould","year":"2012","unstructured":"Gould FK, Denning DW, Elliott TSJ, Foweraker J, Perry JD, Prendergast BD et al (2012) Guidelines for the diagnosis and antibiotic treatment of endocarditis in adults: a report of the Working Party of the British Society for Antimicrobial Chemotherapy. J Antimicrob Chemother 67:269\u2013289. doi: 10.1093\/jac\/dkr450","journal-title":"J Antimicrob Chemother"},{"key":"2488_CR12","unstructured":"Bruun NE, Egeblad H, Elming H, Fuursted K, Hassager C NHK (2014) NBV\u2014Dansk Cardiologisk Selskab. 7. Infekti\u00f8s endocarditis. Available online at: http:\/\/nbv.cardio.dk\/endocarditis#afs7_7"},{"key":"2488_CR13","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1080\/00365540701534517","volume":"39","author":"K Westling","year":"2007","unstructured":"Westling K, Aufwerber E, Ekdahl C, Friman G, G\u00e5rdlund B, Julander I et al (2007) Swedish guidelines for diagnosis and treatment of infective endocarditis. Scand J Infect Dis 39:929\u2013946. doi: 10.1080\/00365540701534517","journal-title":"Scand J Infect Dis"},{"key":"2488_CR14","unstructured":"DANMAP 2013 (2014) Available online at: http:\/\/www.danmap.org\/\u223c\/media\/Projekt%20sites\/Danmap\/DANMAP%20reports\/DANMAP%202013\/DANMAP%202013.ashx"},{"key":"2488_CR15","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1128\/AAC.41.8.1662","volume":"41","author":"JM Entenza","year":"1997","unstructured":"Entenza JM, Vouillamoz J, Glauser MP, Moreillon P (1997) Levofloxacin versus ciprofloxacin, flucloxacillin, or vancomycin for treatment of experimental endocarditis due to methicillin-susceptible or -resistant Staphylococcus aureus. Antimicrob Agents Chemother 41:1662\u20131667","journal-title":"Antimicrob Agents Chemother"},{"key":"2488_CR16","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1093\/jac\/dkr521","volume":"67","author":"P Moreillon","year":"2012","unstructured":"Moreillon P, Bizzini A, Giddey M, Vouillamoz J, Entenza JM (2012) Vancomycin-intermediate Staphylococcus aureus selected during vancomycin therapy of experimental endocarditis are not detected by culture-based diagnostic procedures and persist after treatment arrest. J Antimicrob Chemother 67:652\u2013660. doi: 10.1093\/jac\/dkr521","journal-title":"J Antimicrob Chemother"},{"key":"2488_CR17","doi-asserted-by":"crossref","first-page":"2545","DOI":"10.1007\/s10096-012-1594-x","volume":"31","author":"L Dub\u00e9","year":"2012","unstructured":"Dub\u00e9 L, Caillon J, Jacqueline C, Bugnon D, Potel G, Asseray N (2012) The optimal aminoglycoside and its dosage for the treatment of severe Enterococcus faecalis infection. An experimental study in the rabbit endocarditis model. Eur J Clin Microbiol Infect Dis 31:2545\u20132547. doi: 10.1007\/s10096-012-1594-x","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"2488_CR18","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1160\/TH11-12-0891","volume":"107","author":"T Vanassche","year":"2012","unstructured":"Vanassche T, Kauskot A, Verhaegen J, Peetermans WE, van Ryn J, Schneewind O et al (2012) Fibrin formation by staphylothrombin facilitates Staphylococcus aureus-induced platelet aggregation. Thromb Haemost 107:1107\u20131121. doi: 10.1160\/TH11-12-0891","journal-title":"Thromb Haemost"},{"key":"2488_CR19","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1099\/mic.0.000019","volume":"161","author":"TG Loof","year":"2014","unstructured":"Loof TG, Goldmann O, Naudin C, M\u00f6rgelin M, Neumann Y, Pils MC et al (2014) Staphylococcus aureus-induced clotting of plasma is an immune evasion mechanism for persistence within the fibrin network. Microbiology 161:621\u2013627. doi: 10.1099\/mic.0.000019","journal-title":"Microbiology"},{"key":"2488_CR20","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1111\/j.1699-0463.1998.tb00252.x","volume":"106","author":"A Kjerulf","year":"1998","unstructured":"Kjerulf A, Espersen F, Gutschik E, Majcherczyk PA, Hougen HP, Rygaard J et al (1998) Serological diagnosis of experimental Enterococcus faecalis endocarditis. APMIS 106:997\u20131008","journal-title":"APMIS"},{"key":"2488_CR21","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1128\/AAC.14.3.336","volume":"14","author":"MH Miller","year":"1978","unstructured":"Miller MH, Wexler MA, Steigbigel NH (1978) Single and combination antibiotic therapy of Staphylococcus aureus experimental endocarditis: emergence of gentamicin-resistant mutants. Antimicrob Agents Chemother 14:336\u2013343","journal-title":"Antimicrob Agents Chemother"},{"key":"2488_CR22","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1128\/AAC.31.9.1444","volume":"31","author":"A Rodr\u00edguez","year":"1987","unstructured":"Rodr\u00edguez A, Vicente MV, Olay T (1987) Single- and combination-antibiotic therapy for experimental endocarditis caused by methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother 31:1444\u20131445","journal-title":"Antimicrob Agents Chemother"},{"key":"2488_CR23","doi-asserted-by":"crossref","first-page":"2034","DOI":"10.1128\/AAC.38.9.2034","volume":"38","author":"BJ McGrath","year":"1994","unstructured":"McGrath BJ, Kang SL, Kaatz GW, Rybak MJ (1994) Bactericidal activities of teicoplanin, vancomycin, and gentamicin alone and in combination against Staphylococcus aureus in an in vitro pharmacodynamic model of endocarditis. Antimicrob Agents Chemother 38:2034\u20132040","journal-title":"Antimicrob Agents Chemother"},{"key":"2488_CR24","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1093\/jac\/dkn180","volume":"62","author":"T Tsaganos","year":"2008","unstructured":"Tsaganos T, Skiadas I, Koutoukas P, Adamis T, Baxevanos N, Tzepi I et al (2008) Efficacy and pharmacodynamics of linezolid, alone and in combination with rifampicin, in an experimental model of methicillin-resistant Staphylococcus aureus endocarditis. J Antimicrob Chemother 62:381\u2013383. doi: 10.1093\/jac\/dkn180","journal-title":"J Antimicrob Chemother"},{"key":"2488_CR25","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S0140-6736(03)15266-X","volume":"363","author":"P Moreillon","year":"2004","unstructured":"Moreillon P, Que Y-A (2004) Infective endocarditis. Lancet 363:139\u2013149. doi: 10.1016\/S0140-6736(03)15266-X","journal-title":"Lancet"},{"key":"2488_CR26","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1038\/nrcardio.2013.174","volume":"11","author":"K Werdan","year":"2014","unstructured":"Werdan K, Dietz S, L\u00f6ffler B, Niemann S, Bushnaq H, Silber R-E et al (2014) Mechanisms of infective endocarditis: pathogen\u2013host interaction and risk states. Nat Rev Cardiology 11:35\u201350. doi: 10.1038\/nrcardio.2013.174","journal-title":"Nat Rev Cardiology"},{"key":"2488_CR27","doi-asserted-by":"crossref","first-page":"2436","DOI":"10.1111\/j.1538-7836.2011.04529.x","volume":"9","author":"T Vanassche","year":"2011","unstructured":"Vanassche T, Verhaegen J, Peetermans WE, Van Ryn J, Cheng A, Schneewind O et al (2011) Inhibition of staphylothrombin by dabigatran reduces Staphylococcus aureus virulence. J Thromb Haemost 9:2436\u20132446. doi: 10.1111\/j.1538-7836.2011.04529.x","journal-title":"J Thromb Haemost"}],"container-title":["European Journal of Clinical Microbiology & Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10096-015-2488-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10096-015-2488-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10096-015-2488-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,31]],"date-time":"2019-08-31T03:45:44Z","timestamp":1567223144000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10096-015-2488-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,10,6]]},"references-count":27,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["2488"],"URL":"https:\/\/doi.org\/10.1007\/s10096-015-2488-5","relation":{},"ISSN":["0934-9723","1435-4373"],"issn-type":[{"value":"0934-9723","type":"print"},{"value":"1435-4373","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,10,6]]}}}